Genmab — Juli 2019
-
Genmab løfter mål for børsnotering i USA: Satser på at hente 3,8 milliarder kr.
En ny registrering fra Genmab hos det amerikanske finanstilsyn viser, at selskabet håber på at hente 3,8 milliarder kr. til pengekassen i sin forestående amerikanske børsnotering – 450 mio. kr. mere end tidligere ventet.
(medwatch.dk)
-
-
Enig Bulder.
-
Prospektet ref. fra pressemedd. i går https://ir.genmab.com/news-releases/news-release-details/genmab-commences-public-offering-american-depositary-shares-adss
-
Fra den oprindelige pressemedd. 28.05: ".. The size of such capital increase will depend on the final size of the offering but will in no event exceed the current authorization." Som er 5%, mig bekendt. Altså IKKE mere end tidligere ventet, som Medwatch påstår i kolofonen.
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind
Bliver interessandt og se hvor mange af de nye aktier shorterne for raget til sig